{"id":"W2766277025","doi":"10.1016/j.jval.2017.08.1386","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Costa Rica","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Medicine; Enalapril; Heart failure; Ejection fraction; Internal medicine; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008656238,0.000186341,0.0002426126,0.000252852,0.0002132833,0.0005572559,0.0003514405,0.0001768387,0.001194385],"category_scores_gemma":[0.001115302,0.00006102543,0.0002847809,0.0003209646,0.000315027,0.0001525539,0.0003406564,0.0003669682,0.00009361128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001405305,"about_ca_system_score_gemma":0.002723945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04096967,"about_ca_topic_score_gemma":0.06725975,"domain_scores_codex":[0.999703,0.0001878835,0.00001945965,0.00001426437,0.00002455226,0.0000508368],"domain_scores_gemma":[0.9997041,0.00005064059,0.00009559641,0.00002772675,0.0000594816,0.00006254757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01181694,0.002063377,0.3654518,0.0019024,0.001362052,0.001645521,0.001225148,0.006681697,0.02326708,0.01108863,0.01644873,0.5570467],"study_design_scores_gemma":[0.001740818,0.001745906,0.9480301,0.0006178504,0.001209622,0.0007864336,0.001486554,0.004830376,0.00306992,0.00175283,0.03468474,0.00004485241],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9547054,0.01869739,0.001001103,0.01292378,0.0001037052,0.0001028034,0.000744274,0.00006852733,0.01165296],"genre_scores_gemma":[0.9947679,0.003051539,0.0008275557,0.0006852772,0.00005912212,0.00002909281,0.000132954,0.000006750474,0.0004397416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04096967,"threshold_uncertainty_score":0.08146238,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05966566235948348,"score_gpt":0.3549479626983868,"score_spread":0.2952823003389033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}